RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Atossa Therapeutics - Stock

Atossa Therapeutics Market capitalization 2024

Atossa Therapeutics Market capitalization

147.52 M USD

Ticker

ATOS

ISIN

US04962H5063

WKN

A2JJ99

In 2024, Atossa Therapeutics's market cap stood at 147.52 M USD, a 2.99% increase from the 143.23 M USD market cap in the previous year.

The Atossa Therapeutics Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e558.08-0,02297.18
2028e347.86-0,04183.43
2027e123.7-0,1152.17
2026e55.55-0,23-31.43
2025e---35.06
2024e---29.93
2023---30.09
2022---26.96
2021---20.61
2020---22.33
2019---17.24
2018---22.88
2017---10.69
2016---6.37
2015---15.76
20140.04100,00-14.66
20130.6346,03-10.78
20120.4893,75-5.08
2011---3.44
2010---1.09
2009---0.12

Atossa Therapeutics Aktienanalyse

What does Atossa Therapeutics do?

Atossa Therapeutics Inc. is a biopharmaceutical company based in Seattle, USA, specializing in the development of therapies for the treatment of breast cancer and other breast diseases. Atossa Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Atossa Therapeutics's Market Capitalization

Atossa Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Atossa Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Atossa Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Atossa Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Atossa Therapeutics stock

What is the current Atossa Therapeutics market capitalization?

The current market capitalization of Atossa Therapeutics is 147.52 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Atossa Therapeutics.

How has the market capitalization of Atossa Therapeutics developed in recent years?

The market capitalization of Atossa Therapeutics has increased/decreased by 2.99% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Atossa Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Atossa Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Atossa Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Atossa Therapeutics pay?

Over the past 12 months, Atossa Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Atossa Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Atossa Therapeutics?

The current dividend yield of Atossa Therapeutics is .

When does Atossa Therapeutics pay dividends?

Atossa Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Atossa Therapeutics?

Atossa Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Atossa Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Atossa Therapeutics located?

Atossa Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Atossa Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Atossa Therapeutics from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Atossa Therapeutics pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Atossa Therapeutics in the year 2023?

In the year 2023, Atossa Therapeutics distributed 0 USD as dividends.

In which currency does Atossa Therapeutics pay out the dividend?

The dividends of Atossa Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Atossa Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Atossa Therapeutics

Our stock analysis for Atossa Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Atossa Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.